| abstract |
Since the expression and subcellular localization of human EHD2 protein, particularly the state of expression in the nucleus, significantly correlates with the survival rate of breast cancer patients, it is a molecular marker for the diagnosis of breast cancer malignancy and prognostication. be able to. In the present invention, human EHD2 antibody and its application to the production of a breast cancer immunohistochemical detection reagent are provided. The antibody can specifically recognize human EHD2 protein, and the amino acid sequence of the recognition site is 503-SEQ ID NO: 1 to 543. [Selection] Figure 6 |